News
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...
Explore more
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without ...
Zepbound led to. With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, ...
Zepbound, released last November by pharma giant Eli Lilly, is in limited supply through the end of the month due to what the Food and Drug Administration says is a “demand increase. ...
Tirzepatide is the active ingredient in Zepbound and in Eli Lilly's diabetes counterpart Mounjaro, which are part of a class of highly popular medications called GLP-1s.. She said compounded ...
Zepbound brought in $2.3 billion in U.S. sales during this year’s first quarter, making it one of drugmaker Eli Lilly’s best sellers. Novo Nordisk says Wegovy has about 200,000 weekly ...
Her copay for Zepbound has been around $10 per month since she started the drug in March. Skala said she has lost 52 pounds and noticed "profound improvements" in her mental health, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results